Happy Valentine's Day! You Will LOVE Our February Best Buys:
Feb 14, 2024
7investing shares some Valentine's Day love with its February Best Buys in the stock market.
Is Tech Hiring Picking Back Up?
Feb 15, 2024
Encouraging data shows that (some) tech companies are looking for new engineering talent.
AI is Bringing Synthetic Biology Back to Life
Feb 6, 2024
New AI tools could supercharge the emerging field of generative biology. The therapeutics segment might be a natural fit.
Investing in the Cloud: Mission-Critical, Land-and-Expand, and Sustainable Growth
Jan 22, 2024
Guest contributor Anand Khatri from StocksCurrent describes how investors should approach the cloud computing industry.
2024 NFL Mock Draft 1.0
Jan 21, 2024
7investing CEO Simon Erickson shares his mock draft outlook of what NFL fans should expect this April.
Why Seres Therapeutics is My Best Buy in January
Jan 17, 2024
The market's first microbiome company is getting a good reception to its first commercially-approved drug.
ZoomInfo: Time for a Turnaround?
Jan 11, 2024
The sales platform looks primed for a turnaround.
How Do Renewable Energy Projects Get Evaluated?
Dec 28, 2023
7investing CEO Simon Erickson shares a primer on how renewable projects tend to be evaluated by larger energy companies.
TaskUs is “Dirt Cheap”; My Review of its Q3 2023…
Dec 11, 2023
7investing advisor Anirban Mahanti shares his thoughts about TaskUs' most recent quarterly results.
Is Seres Therapeutics Preparing To Be Acquired?
Nov 3, 2023
Seres Therapeutics announced great initial sales data but also a company restructuring. Is it preparing for an upcoming acquisition?